Renaissance Technologies’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $594K | Sell |
67,190
-21,235
| -24% | -$188K | ﹤0.01% | 2753 |
|
|
2025
Q1 | $951K | Buy |
88,425
+7,818
| +10% | +$84.1K | ﹤0.01% | 2457 |
|
|
2024
Q4 | $1.03M | Buy |
80,607
+70,737
| +717% | +$905K | ﹤0.01% | 2482 |
|
|
2024
Q3 | $272K | Buy |
9,870
+2,255
| +30% | +$62.2K | ﹤0.01% | 3010 |
|
|
2024
Q2 | $221K | Sell |
7,615
-13,560
| -64% | -$393K | ﹤0.01% | 3011 |
|
|
2024
Q1 | $944K | Buy |
21,175
+17,550
| +484% | +$782K | ﹤0.01% | 2523 |
|
|
2023
Q4 | $141K | Buy |
+3,625
| New | +$141K | ﹤0.01% | 3226 |
|
|
2022
Q4 | – | Sell |
-2,035
| Closed | -$298K | – | 4280 |
|
|
2022
Q3 | $298K | Sell |
2,035
-475
| -19% | -$69.6K | ﹤0.01% | 3216 |
|
|
2022
Q2 | $327K | Sell |
2,510
-165
| -6% | -$21.5K | ﹤0.01% | 3404 |
|
|
2022
Q1 | $270K | Buy |
+2,675
| New | +$270K | ﹤0.01% | 3515 |
|